CAS 896731-82-1: Conatumumab
Formula:Unspecified
- Sinonimi:
- Conatumumab
- Immunoglobulin G1, anti-(human cytokine receptor DR5 (death receptor 5)) (human monoclonal XG1-048 v w heavy chain), disulfide with human monoclonal XG1-048 v w light chain, dimer
- Immunoglobulin G1, anti-(human TRAIL receptor 2) (human monoclonal XG1-048 v w heavy chain), disulfide with human monoclonal XG1-048 v w light chain, dimer
- AMG 655
- TRAIL-R2 mAb
| Marchio | Dati del prodotto | Purezza | Fascia di prezzo | Consegna prevista |
|---|---|---|---|---|
 | Conatumumab REF: TM-T76787CAS: 896731-82-1 | > 95% - > 95% | 359,00 €~1.454,00 € | Mar 08 Apr 25 |
 | Conatumumab REF: 3D-CLA1171CAS: 896731-82-1 | - - - | Prezzo su richiesta | Mer 16 Apr 25 |
Conatumumab
CAS:896731-82-1
Conatumumab (AMG 655) targets DR5 to induce apoptosis in tumors, with Kd of 1 nM …
Purezza:
> 95% - > 95%
Colore e forma:
Liquid
Peso molecolare:
145 kDa (average)
Ref: TM-T76787
| 1mg | 359,00 € | ||
| 5mg | 908,00 € | ||
| 10mg | 1.454,00 € |
Consegna stimata in Stati Uniti, il Martedì 08 Aprile 2025
Conatumumab
CAS:896731-82-1
A fully human monoclonal agonist antibody against the extracellular domain of human TRAIL.
Ref: 3D-CLA1171
| Dimensione non definita | Prezzo su richiesta |
Consegna stimata in Stati Uniti, il Mercoledì 16 Aprile 2025
